Cymantrene–Triazole "Click" Products: Structural Characterization and Electrochemical Properties

We report the first known examples of triazole-derivatized cymantrene complexes (η5-[4-substituted triazol-1-yl]cyclopentadienyl)tricarbonylmanganese(I), obtained via a “click” chemical synthesis, bearing a phenyl, 3-aminophenyl, or 4-aminophenyl moiety at the 4-position of the triazole ring. Structural characterization data using multinuclear NMR, UV–vis, ATR-IR, and mass spectrometric methods are provided, as well as crystallographic data for (η5-[4-phenyltriazol-1-yl]cyclopentadienyl)tricarbonylmanganese(I) and (η5-[4-(3-aminophenyl)triazol-1-yl]cyclopentadienyl)tricarbonylmanganese(I). Cyclic voltammetric characterization of the redox behavior of each of the three cymantrene–triazole complexes is presented together with digital simulations, in situ infrared spectroelectrochemistry, and DFT calculations to extract the associated kinetic and thermodynamic parameters. The trypanocidal activity of each cymantrene–triazole complex is also examined, and these complexes are found to be more active than cymantrene alone

Hall Measurements on Carbon Nanotube Paper Modified With Electroless Deposited Platinum

Carbon nanotube paper, sometimes referred to as bucky paper, is a random arrangement of carbon nanotubes meshed into a single robust structure, which can be manipulated with relative ease. Multi-walled carbon nanotubes were used to make the nanotube paper, and were subsequently modified with platinum using an electroless deposition method based on substrate enhanced electroless deposition. This involves the use of a sacrificial metal substrate that undergoes electro-dissolution while the platinum metal deposits out of solution onto the nanotube paper via a galvanic displacement reaction. The samples were characterized using SEM/EDS, and Hall-effect measurements. The SEM/EDS analysis clearly revealed deposits of platinum (Pt) distributed over the nanotube paper surface, and the qualitative elemental analysis revealed co-deposition of other elements from the metal substrates used. When stainless steel was used as sacrificial metal a large degree of Pt contamination with various other metals was observed. Whereas when pure sacrificial metals were used bimetallic Pt clusters resulted. The co-deposition of a bimetallic system upon carbon nanotubes was a function of the metal type and the time of exposure. Hall-effect measurements revealed some interesting fluctuations in sheet carrier density and the dominant carrier switched from N- to P-type when Pt was deposited onto the nanotube paper. Perspectives on the use of the nanotube paper as a replacement to traditional carbon cloth in water electrolysis systems are also discussed

Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention::A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial

Background: The tradeoff in safety versus efficacy in substituting a non-vitamin K antagonist oral anticoagulant for a vitamin K antagonist (VKA) in the stented atrial fibrillation patient has not been quantitatively evaluated. Methods: Based on summary data from the PIONEER AF-PCI and RE-DUAL PCI trials, 4 antithrombotic regimens were compared with VKA-based triple therapy: (1) rivaroxaban (riva) 15 mg daily + P2Y(12) inhibitor, (2) riva 2.5 mg twice daily + P2Y(12) inhibitor + aspirin, (3) dabigatran (dabi) 110 mg twice daily + P2Y(12) inhibitor, and (4) dabi 150 mg twice daily + P2Y(12) inhibitor. A bivariate model with a noninferiority margin of 1.38 was used to simultaneously assess safety and efficacy. The safety end point was major or clinically relevant nonmajor bleeding by International Society on Thrombosis and Haemostasis definitions. The efficacy end point was a thromboembolic event (myocardial infarction, stroke, or systemic embolism), death, or urgent revascularization. The bivariate outcome, a measure of risk difference in the net clinical outcome, was compared between antithrombotic regimens. Results: All 4 non-vitamin K antagonist oral anticoagulant regimens were superior in bleeding and noninferior in efficacy compared with triple therapy with VKA. Riva 15 mg daily and 2.5 mg twice daily were associated with bivariate combined risk reductions of 5.6% (2.3%-8.8%) and 5.5% (2.1%-8.7%), respectively, and dabi 110 mg twice daily and 150 mg twice daily reduced the bivariate risk by 3.8% (0.5%-7.0%) and 6.3% (2.4%-9.8%), respectively. Conclusions: A bivariate analysis that simultaneously characterizes both risk and benefit demonstrates that riva-and dabi-based regimens were both favorable over VKA plus dual antiplatelet therapy among patients with atrial fibrillation undergoing PCI. (C) 2018 Elsevier Inc. All rights reserved

Review: The increasing importance of carbon nanotubes and nanostructured conducting polymers in biosensors

The growing need for analytical devices requiring smaller sample volumes, decreased power consumption and improved performance have been driving forces behind the rapid growth in nanomaterials research. Due to their dimensions, nanostructured materials display unique properties not traditionally observed in bulk materials. Characteristics such as increased surface area along with enhanced electrical/optical properties make them suitable for numerous applications such as nanoelectronics, photovoltaics and chemical/biological sensing. In this review we examine the potential that exists to use nanostructured materials for biosensor devices. By incorporating nanomaterials, it is possible to achieve enhanced sensitivity, improved response time and smaller size. Here we report some of the success that has been achieved in this area. Many nanoparticle and nanofibre geometries are particularly relevant, but in this paper we specifically focus on organic nanostructures, reviewing conducting polymer nanostructures and carbon nanotubes

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Contains fulltext : 169804.pdf (publisher's version ) (Open Access)BACKGROUND: Patients with atrial fibrillation who undergo intracoronary stenting traditionally are treated with a vitamin K antagonist (VKA) plus dual antiplatelet therapy (DAPT), yet this treatment leads to high risks of bleeding. We hypothesized that a regimen of rivaroxaban plus a P2Y12 inhibitor monotherapy or rivaroxaban plus DAPT could reduce bleeding and thereby have a favorable impact on all-cause mortality and the need for rehospitalization. METHODS: Stented subjects with nonvalvular atrial fibrillation (n=2124) were randomized 1:1:1 to administration of reduced-dose rivaroxaban 15 mg daily plus a P2Y12 inhibitor for 12 months (group 1); rivaroxaban 2.5 mg twice daily with stratification to a prespecified duration of DAPT of 1, 6, or 12 months (group 2); or the reference arm of dose-adjusted VKA daily with a similar DAPT stratification (group 3). The present post hoc analysis assessed the end point of all-cause mortality or recurrent hospitalization for an adverse event, which was further classified as the result of bleeding, a cardiovascular cause, or another cause blinded to treatment assignment. RESULTS: The risk of all-cause mortality or recurrent hospitalization was 34.9% in group 1 (hazard ratio=0.79; 95% confidence interval, 0.66-0.94; P=0.008 versus group 3; number needed to treat=15), 31.9% in group 2 (hazard ratio=0.75; 95% confidence interval, 0.62-0.90; P=0.002 versus group 3; number needed to treat=10), and 41.9% in group 3 (VKA+DAPT). Both all-cause death plus hospitalization potentially resulting from bleeding (group 1=8.6% [P=0.032 versus group 3], group 2=8.0% [P=0.012 versus group 3], and group 3=12.4%) and all-cause death plus rehospitalization potentially resulting from a cardiovascular cause (group 1=21.4% [P=0.001 versus group 3], group 2=21.7% [P=0.011 versus group 3], and group 3=29.3%) were reduced in the rivaroxaban arms compared with the VKA arm, but other forms of rehospitalization were not. CONCLUSIONS: Among patients with atrial fibrillation undergoing intracoronary stenting, administration of either rivaroxaban 15 mg daily plus P2Y12 inhibitor monotherapy or 2.5 mg rivaroxaban twice daily plus DAPT was associated with a reduced risk of all-cause mortality or recurrent hospitalization for adverse events compared with standard-of-care VKA plus DAPT. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01830543

High catalytic activity of oriented 2.0.0 copper(I) oxide grown on graphene film

[EN] Metal oxide nanoparticles supported on graphene exhibit high catalytic activity for oxidation, reduction and coupling reactions. Here we show that pyrolysis at 900 C under inert atmosphere of copper(II) nitrate embedded in chitosan films affords 1.1.1 facet-oriented copper nanoplatelets supported on few-layered graphene. Oriented (1.1.1) copper nanoplatelets on graphene undergo spontaneous oxidation to render oriented (2.0.0) copper(I) oxide nanoplatelets on few-layered graphene. These films containing oriented copper(I) oxide exhibit as catalyst turnover numbers that can be three orders of magnitude higher for the Ullmann-type coupling, dehydrogenative coupling of dimethylphenylsilane with n-butanol and C–N cross-coupling than those of analogous unoriented graphene-supported copper(I) oxide nanoplatelets.Financial support by the Spanish Ministry of Economy and Competitiveness (Severo Ochoa and CTQ2012-32315) and Generalitat Valenciana (Prometeo 2013-019) is gratefully acknowledged. Partial financial support from European Union (Being Energy project) is also acknowledged. J.F.B. and I. E.-A. thank the Technical University of Valencia and the Spanish Ministry of Science for PhD scholarships, respectively. The authors are grateful to Mrs. Amparo Forneli for her assistance in the sample preparation and to Dr. Agouram Said from SCSIE, University of Valencia for the sample preparation and HRTEM characterization of samples. AD thanks University Grants Commission, New Delhi, for the award of Assistant Professorship under its Faculty Recharge Programme. AD also thanks Department of Science and Technology, India, for the financial support through Fast Track project (SB/FT/CS-166/2013) and the Generalidad Valenciana for financial aid supporting his stay at Valencia through the Prometeo programme. VP thanks UEFISCDI for financial support through PN-II-ID-PCE-2011-3-0060 project (275/2011).Primo Arnau, AM.; Esteve Adell, I.; Blandez Barradas, JF.; Amarajothi, D.; Alvaro Rodríguez, MM.; Candu, N.; Coman, SM.... (2015). High catalytic activity of oriented 2.0.0 copper(I) oxide grown on graphene film. Nature Communications. 6. https://doi.org/10.1038/ncomms9561S85616Huang, J. et al. Nanocomposites of size-controlled gold nanoparticles and graphene oxide: formation and applications in SERS and catalysis. Nanoscale 2, 2733–2738 (2010).Li, X., Wang, X., Song, S., Liu, D. & Zhang, H. Selectively deposited noble metal nanoparticles on fe3o4/graphene composites: stable, recyclable, and magnetically separable catalysts. Chem. Eur. J. 18, 7601–7760 (2012).Liang, Y. et al. Covalent hybrid of spinel manganese-cobalt oxide and graphene as advanced oxygen reduction electrocatalysts. J. Am. Chem. Soc. 134, 3517–3523 (2012).Ghanbarlou, H., Rowshanzamir, S., Kazeminasab, B. & Parnian, M. J. Non-precious metal nanoparticles supported on nitrogen-doped graphene as a promising catalyst for oxygen reduction reaction: synthesis, characterization and electrocatalytic performance. J. Power Sources 273, 981–989 (2015).Chu, H. et al. Ionic-liquid-assisted preparation of carbon nanotube-supported uniform noble metal nanoparticles and their enhanced catalytic performance. Adv. Funct. Mater. 20, 3747–3752 (2010).Ramulifho, T., Ozoemena, K. I., Modibedi, R. M., Jafta, C. J. & Mathe, M. K. Fast microwave-assisted solvothermal synthesis of metal nanoparticles (Pd, Ni, Sn) supported on sulfonated MWCNTs: Pd-based bimetallic catalysts for ethanol oxidation in alkaline medium. Electrochim. Acta 59, 310–320 (2012).Wang, Y., Zhao, Y., He, W., Yin, J. & Su, Y. Palladium nanoparticles supported on reduced graphene oxide: facile synthesis and highly efficient electrocatalytic performance for methanol oxidation. Thin Solid Films 544, 88–92 (2013).He, Y. et al. Metal nanoparticles supported graphene oxide 3D porous monoliths and their excellent catalytic activity. Mater. Chem. Phys. 134, 585–589 (2012).Li, Z. et al. One-pot synthesis of pd nanoparticle catalysts supported on n-doped carbon and application in the domino carbonylation. ACS Catal. 3, 839–845 (2013).Xiang, G., He, J., Li, T., Zhuang, J. & Wang, X. Rapid preparation of noble metal nanocrystals via facile coreduction with graphene oxide and their enhanced catalytic properties. Nanoscale 3, 3737–3742 (2011).Li, Z. et al. Experimental and DFT studies of gold nanoparticles supported on MgO(111) nano-sheets and their catalytic activity. Phys. Chem. Chem. Phys. 13, 2582–2589 (2011).Ding, M., Tang, Y. & Star, A. Understanding interfaces in metal-graphitic hybrid nanostructures. J. Phys. Chem. Lett. 4, 147–160 (2013).Wildgoose, G. G., Banks, C. E. & Compton, R. G. Metal nanoparticles and related materials supported on carbon nanotubes: methods and applications. Small 2, 182–193 (2006).Blandez, J. F., Primo, A., Asiri, A. M., Álvaro, M. & García, H. Copper nanoparticles supported on doped graphenes as catalyst for the dehydrogenative coupling of silanes and alcohols. Angew. Chem. Int. Ed. 53, 12581–12586 (2014).Yang, M. Q., Zhang, N., Pagliaro, M. & Xu, Y. J. Artificial photosynthesis over graphene-semiconductor composites. Are we getting better? Chem. Soc. Rev. 43, 8240–8254 (2014).Zhang, N., Zhang, Y. & Xu, Y. J. Recent progress on graphene-based photocatalysts: current status and future perspectives. Nanoscale 4, 5792–5813 (2012).Parga, A. L. V. de., Ha nacido una estrella. El grafeno. An. Quím. 107, 213–220 (2011).Rao, C. N. R., Sood, A. K., Subrahmanyam, K. S. & Govindaraj, A. Graphene: the new two-dimensional nanomaterial. Angew. Chem. Int. Ed. 48, 7752–7777 (2009).Sun, T. et al. Facile and green synthesis of palladium nanoparticles-graphene-carbon nanotube material with high catalytic activity. Nature 3, 1–6 (2013).Yoo, E. et al. Enhanced electrocatalytic activity of Pt subnanoclusters on graphene nanosheet surface. Nano Lett. 9, 2255–2259 (2009).Jin, X. et al. Lattice-matched bimetallic CuPd-graphene nanocatalysts for facile conversion of biomass-derived polyols to chemicals. ACS Nano 7, 1309–1316 (2013).Hong, C. et al. Graphene oxide stabilized Cu2O for shape selective nanocatalysis. J. Mater. Chem. A 2, 7147–7151 (2014).Reina, A. et al. Large area, few-layer graphene films on arbitrary substrates by chemical vapor deposition. Nano Lett. 9, 30–35 (2008).Wei, D. et al. Synthesis of N-doped graphene by chemical vapor deposition and its electrical properties. Nano Lett. 9, 1752–1758 (2009).Kim, K. S. et al. Large-scale pattern growth of graphene films for stretchable transparent electrodes. Nature 457, 706–710 (2009).Li, X. et al. Large-area graphene single crystals grown by low-pressure chemical vapor deposition of methane on copper. J. Am. Chem. Soc. 133, 2816–2819 (2011).Mattevi, C., Kima, H. & Chhowalla, M. A review of chemical vapour deposition of graphene on copper. J. Mater. Chem. 21, 3324–3334 (2010).Liu, W., Li, H., Xu, C., Khatami, Y. & Banerjee, K. Synthesis of high-quality monolayer and bilayer graphene on copper using chemical vapor deposition. Carbon 49, 4122–4130 (2011).Losurdo, M., Giangregorio, M. M., Capezzuto, P. & Bruno, G. Graphene CVD growth on copper and nickel: role of hydrogen in kinetics and structure. Phys. Chem. Chem. Phys. 13, 20836–20843 (2011).Gao, L., Guest, J. R. & Guisinguer, N. P. Epitaxial graphene on Cu (111). Nano Lett. 10, 3512–3516 (2010).Zhao, L. et al. Influence of copper crystal surface on the growth of large area monolayer graphene. Solid State Commun. 151, 509–513 (2011).Wood, J. D., Schmucker, S. W., Lyons, A. S., Pop, E. & Lyding, J. W. Effects of polycrystalline Cu substrate on graphene growth by chemical vapor deposition. Nano Lett. 11, 4547–4554 (2011).Primo, A., Atienzar, P., Sanchez, E., Delgado, J. M. & Garcia, H. From biomass wastes to large-area, high-quality, N-doped graphene: catalyst-free carbonization of chitosan coatings on arbitrary substrates. Chem. Commun. 48, 9254–9256 (2012).Primo, A., Sánchez, E., Delgado, J. M. & García, H. High-yield production of N-doped graphitic platelets by aqueous exfoliation of pyrolyzed chitosan. Carbon 68, 777–783 (2014).Primo, A., Forneli, A., Corma, A. & García, H. From biomass wastes to highly efficient CO2 adsorbents: graphitisation of chitosan and alginate biopolymers. ChemSusChem. 5, 2207–2214 (2012).Ravi Kumar, M. N. V. A review of chitin and chitosan applications. React. Funct. Polym. 46, 1–27 (2000).Rinaudo, M. Chitin and chitosan: properties and applications. Prog. Polym. Sci. 31, 603–632 (2006).Rinaudo, M. Main properties and current applications of some polysaccharides as biomaterials. Polym. Int. 57, 397–430 (2008).Latorre-Sanchez, M. et al. The synthesis of a hybrid graphene-nickel/manganese mixed oxide and its performance in lithium-ion batteries. Carbon 50, 518–525 (2012).Park, B. K. et al. Synthesis and size control of monodisperse copper nanoparticles by polyol method. J. Colloid Interface Sci. 311, 417–424 (2007).Lavorato, C., Primo, A., Molinari, R. & Garcia, H. Natural alginate as a graphene precursor and template in the synthesis of nanoparticulate ceria/graphene water oxidation photocatalysts. ACS Catal. 4, 497–504 (2014).Wu, S. et al. Electrochemical deposition of Cl-doped n-type Cu2O on reduced graphene oxide electrodes. J. Mater. Chem. 21, 3467–3470 (2011).Jiang, L. et al. Surface-enhanced Raman scattering spectra of adsorbates on Cu2O nanospheres: charge-transfer and electromagnetic enhancement. Nanoscale 5, 2784–2789 (2013).Sridhara Rao, D. V., Muraleedharan, K. & Humphreys, C. J. Microscopy Science, Technology, Applications and Education Vol. 2, 1232–1244Formatex, Badajos (2011).Lewin, A. H. & Cohen, T. The mechanism of the Ullman reaction. Detection of an organocopper intermediate. Tetrahedron Lett. 6, 4531–4536 (1965).Hassan, J., Sévignon, M., Gozzi, C., Schulz, E. & Lemaire, M. Aryl-aryl bond formation one century after the discovery of the Ullmann reaction. Chem. Rev. 102, 1359–1469 (2002).Ma, D., Cai, Q. & Zhang, H. Mild method for Ullman coupling reaction of amines and aryl halides. Org. Lett. 5, 2453–2455 (2003).Li, Y., Gao, W., Ci, L., Wang, C. & Ajayan, P. M. Catalytic performance of Pt nanoparticles on reduced graphene oxide for methanol electro-oxidation. Carbon 48, 1124–1130 (2010).Ong, W.-J., Tan, L.-L., Chai, S.-P. & Yong, S.-T. Heterojunction engineering of graphitic carbon nitride (g-C3N4) via Pt loading with improved daylight-induced photocatalytic reduction of carbon dioxide to methane. Dalton Trans. 44, 1249–1257 (2015).Luo, C., Zhang, Y., Zeng, X., Zeng, Y. & Wang, Y. The role of poly(ethylene glycol) in the formation of silver nanoparticles. J. Colloid Interface Sci. 288, 444–448 (2005).Wu, S.-H. & Chen, D.-H. Synthesis and characterization of nickel nanoparticles by hydrazine reduction in ethylene glycol. J. Colloid Interface Sci. 259, 282–286 (2003).Hou, Z., Theyssen, N., Brinkmann, A. & Leitner, W. Biphasic aerobic oxidation of alcohols catalyzed by poly(ethylene glycol)-stabilized palladium nanoparticles in supercritical carbon dioxide. Angew. Chem. Int. Ed. 117, 1370–1373 (2005).Dhakshinamoorthy, A., Navalon, S., Sempere, D., Alvaro, M. & Garcia, H. Reduction of alkenes catalyzed by copper nanoparticles supported on diamond nanoparticles. Chem. Commun. 49, 2359–2361 (2013).Ito, H., Watanabe, A. & Sawamura, M. Versatile dehydrogenative alcohol silylation catalyzed by Cu (I)-phosphine complex. Org. Lett. 7, 1869–1871 (2005).Rendler, S. et al. Stereoselective alcohol silylation by dehydrogenative Si-O coupling: scope, limitations, and mechanism of the Cu-H-catalyzed non-enzimatic kinetic resolution with silicon-stereogenic silanes. Chem. Eur. J. 14, 11512–11528 (2008).Cristau, H. J., Cellier, P. P., Spindler, J. F. & Taillefer, M. Highly efficient and mild copper-catalyzed N- and C-arylations with aryl bromides and iodides. Chemistry 10, 5607–5622 (2004).Shafir, A. & Buchwald, S. L. Highly selective room-temperature copper-catalyzed C-N coupling reactions. J. Am. Chem. Soc. 128, 8742–8743 (2006)

Weaning practices in phenylketonuria vary between health professionals in Europe

Background: In phenylketonuria (PKU), weaning is considered more challenging when compared to feeding healthy infants. The primary aim of weaning is to gradually replace natural protein from breast milk or standard infant formula with solids containing equivalent phenylalanine (Phe). In addition, a Phe-free second stage L-amino acid supplement is usually recommended from around 6 months to replace Phe-free infant formula. Our aim was to assess different weaning approaches used by health professionals across Europe. Methods: A cross sectional questionnaire (survey monkey (R)) composed of 31 multiple and single choice questions was sent to European colleagues caring for inherited metabolic disorders (IMD). Centres were grouped into geographical regions for analysis. Results: Weaning started at 17-26 weeks in 85% (n=81/95) of centres, > 26 weeks in 12% (n=11/95) and 26 weeks. First solids were mainly low Phe vegetables (59%, n=56/95) and fruit (34%, n=32/95). A Phe exchange system to allocate dietary Phe was used by 52% (n=49/95) of centres predominantly from Northern and Southern Europe and 48% (n=46/95) calculated most Phe containing food sources (all centres in Eastern Europe and the majority from Germany and Austria). Some centres used a combination of both methods. A second stage Phe-free L-amino acid supplement containing a higher protein equivalent was introduced by 41% (n=39/95) of centres at infant age 26-36 weeks (mainly from Germany, Austria, Northern and Eastern Europe) and 37% (n=35/95) at infant age > 1y mainly from Southern Europe. 53% (n=50/95) of centres recommended a second stage Phe-free L-amino acid supplement in a spoonable or semi-solid form. Conclusions: Weaning strategies vary throughout European PKU centres. There is evidence to suggest that different infant weaning strategies may influence longer term adherence to the PKU diet or acceptance of Phe-free L-amino acid supplements; rendering prospective long-term studies important. It is essential to identify an effective weaning strategy that reduces caregiver burden but is associated with acceptable dietary adherence and optimal infant feeding development.Peer reviewe

Early feeding practices in infants with phenylketonuria across Europe

Background: In infants with phenylketonuria (PKU), dietary management is based on lowering and titrating phenylalanine (Phe) intake from breast milk or standard infant formula in combination with a Phe-free infant formula in order to maintain blood Phe levels within target range. Professionals use different methods to feed infants with PKU and our survey aimed to document practices across Europe. Methods: We sent a cross sectional, survey monkey (R) questionnaire to European health professionals working in IMD. It contained 31 open and multiple-choice questions. The results were analysed according to different geographical regions. Results: Ninety-five centres from 21 countries responded. Over 60% of centres commenced diet in infants by age 10 days, with 58% of centres implementing newborn screening by day 3 post birth. At diagnosis, infant hospital admission occurred in 61% of metabolic centres, mainly in Eastern, Western and Southern Europe. Breastfeeding fell sharply following diagnosis with only 30% of women still breast feeding at 6 months. 53% of centres gave pre-measured Phe-free infant formula before each breast feed and 23% alternated breast feeds with Phe-free infant formula. With standard infant formula feeds, measured amounts were followed by Phe-free infant formula to satiety in 37% of centres (n = 35/95), whereas 44% (n = 42/95) advised mixing both formulas together. Weaning commenced between 17 and 26 weeks in 85% centres, >= 26 weeks in 12% and <17 weeks in 3%. Discussion: This is the largest European survey completed on PKU infant feeding practices. It is evident that practices varied widely across Europe, and the practicalities of infant feeding in PKU received little focus in the PKU European Guidelines (2017). There are few reports comparing different feeding techniques with blood Phe control, Phe fluctuations and growth. Controlled prospective studies are necessary to assess how different infant feeding practices may influence longer term feeding development.Peer reviewe